|
TMCC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.571780E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.902500E-03 |
| Normal-vs-Stage2 |
9.813800E-01 |
| Normal-vs-Stage3 |
9.903600E-02 |
| Normal-vs-Stage4 |
2.558800E-01 |
| Stage1-vs-Stage2 |
5.003900E-02 |
| Stage1-vs-Stage3 |
4.728200E-01 |
| Stage1-vs-Stage4 |
1.895780E-01 |
| Stage2-vs-Stage3 |
2.065800E-01 |
| Stage2-vs-Stage4 |
3.769800E-01 |
| Stage3-vs-Stage4 |
6.196200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.242000E-03 |
| Normal-vs-AfricanAmerican |
3.152400E-02 |
| Normal-vs-Asian |
1.032230E-01 |
| Caucasian-vs-AfricanAmerican |
3.113600E-01 |
| Caucasian-vs-Asian |
7.965400E-01 |
| AfricanAmerican-vs-Asian |
2.766800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.137600E-02 |
| Normal-vs-Female |
1.638250E-02 |
| Male-vs-Female |
7.550800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.503300E-03 |
| Normal-vs-Age(41-60Yrs) |
4.052000E-02 |
| Normal-vs-Age(61-80Yrs) |
5.790800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.265200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.570800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.742300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.816250E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.028200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.816000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.421600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.067600E-01 |
| Classical-VS-Follicular |
2.26849999895862E-08 |
| Classical-VS-Other |
3.260000E-01 |
| Classical-VS-Normal |
1.204480E-04 |
| Tall-VS-Follicular |
3.561600E-02 |
| Tall-VS-Other |
7.341000E-01 |
| Tall-VS-Normal |
2.128200E-01 |
| Follicular-VS-Other |
4.063400E-01 |
| Follicular-VS-Normal |
1.385190E-01 |
| Other-VS-Normal |
7.248200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.430200E-01 |
| Normal-vs-N1 |
4.342200E-01 |
| N0-vs-N1 |
9.156000E-01 |
|
|
